Systemic Lupus Erythematosus (SLE) Clinical Research
We know Systemic Lupus Erythematosus (SLE) can affect every area of your life. A new Systemic Lupus Erythematosus (SLE) Clinical Trial for adults living with Systemic Lupus Erythematosus (SLE). This nationwide study is evaluating a new investigational medication to reduce symptoms of Systemic Lupus Erythematosus (SLE).
Eligibility
To take part in the study, participants should:
- Be 18 to 75 years of age
- Have a diagnosis of active systemic lupus erythematosus (SLE)
- Have not been diagnosed with other autoimmune diseases (for example, multiple sclerosis, psoriasis, inflammatory bowel disease, etc.)
Study details
- Compensation for time and travel is available
-
No health insurance is required
- Study related drug and care from a dedicated medical staff will be provided at no cost
- The study will help to develop a potential treatment for Systemic Lupus Erythematosus (SLE)
Need help? Have questions?
Contact Us
Call or text: (805) 705-5872
Email: contact@clinicallymedia.com
